Benzodiazepine drugs are psychoactive drug that are used to treat disorders such as anxiety, insomnia, panic disorder, and alcohol addiction. These drugs provide a soothing effect by enhancing the neurotransmitter GABA. The use of benzodiazepine drugs has served many people to balance their anxiety syndrome and lead a normal life. Taking into consideration the current scenario of stressful and hectic lifestyle, the benzodiazepine drugs market is anticipated to grow at a rapid rate.
According to the recent studies by World Health Organization (WHO), there is a substantial increase in cases of anxiety disorders among male and female population. However, the percentage of female population with anxiety disorder is more as compared to male population. These statistics have been vital in driving the growth parameters of the benzodiazepine drugs market.
Rapid urbanization and modern work culture have a significant influence on the mental health of people.. There is noteworthy increase in issues such as insomnia, anxiety, and depression due to excessive use of technology and high work pressure. Furthermore, the geriatric population is suffering largely with sleep and panic disorders. Rise in awareness among the masses about the importance of mental health has boosted the demand for diagnosis and medication. In addition, sizable demand for therapies such as cognitive behavior therapy (CBT) and effective anti-depressants is observed in the recent years. The aforementioned factors are creating substantial growth prospects in the benzodiazepine drugs market.
The benzodiazepine drugs market has been categorized into long acting, short acting and ultra-short acting. Players in the benzodiazepine drugs market are focusing strengthening their distribution channels, which include hospitals, pharmacies, retail pharmacies, online and mail pharmacies.
The key market players are investing in R&D activities to enhance the effectiveness of benzodiazepine drugs used for sedation, inducing sleep, and anxiety reduction with minimal side effects. Moreover, companies are investing in small start-ups and using varied strategies such as mergers, acquisitions, joint ventures, and partnerships in order to maintain their dominance in the benzodiazepine drugs market.
Benzodiazepines is a class of psychoactive drugs that are used to treat anxiety, insomnia, panic disorder, seizures, and alcohol withdrawal. These drug produce a calming effect by enhancing the effect of the neurotransmitter GABA. Benzodiazepines are widely prescribed drugs across the world. They are helpful to reduce anxiety, seizures, relax muscles, inducing sleep, and used for sedation purposes prior to surgery or general anesthesia. The global benzodiazepine drugs market was valued at around US $ 2,055 Mn in 2017. It is expected to expand at a CAGR of 2.7% from 2018 to 2026. The Alprazolam segment dominates the global market in terms of value. The market for benzodiazepine drugs is expanding significantly due to the rise in prevalence of anxiety, seizures, insomnia, and increase in concern among people about preventive measures regarding stress-related conditions. Increased adoption of generic drugs and comparatively higher prescriptions for benzodiazepines, as compared to other psychoactive drugs, also drive the market.
The benzodiazepine drugs market has been segmented based on product, application, time of action, distribution channel, and region. Based on product, the global market has been divided into Alprazolam, Clonazepam, Diazepam, Lorazepam, and others. The Alprazolam segment dominated the global market in 2017. It is projected to expand at a higher CAGR due to more number of prescriptions and wide applications in anxiety and seizures. Based on application, the global benzodiazepine drugs market has been classified into anxiety, insomnia, alcohol withdrawal, seizures, and others. Anxiety was the dominant segment of the market in 2017. It is expected to expand at a higher CAGR, owing to the rise in prevalence of anxiety and panic disorders and the better calming effect produced by benzodiazepines. In terms of time of action, the global benzodiazepine drugs market has been classified into ultra-short acting, short acting, and long acting. The short acting segment dominated the market in 2017. It is expected to maintain its position due to less hangover effect and faster onset of action. Based on distribution channel, the global benzodiazepine drugs market has been segregated into hospital pharmacies, retail pharmacies, and others. The others segment, which comprises online pharmacies and mail pharmacies, is projected to expand at a significantly higher CAGR during the forecast period. This expanded CAGR is attributed to discounted prices and convenience of usage.
In terms of region, the global benzodiazepine drugs market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global benzodiazepine drugs market in 2017, owing to the rise in prevalence of anxiety and related conditions and higher FDA approvals of benzodiazepine drugs by major players in the region. Asia Pacific and Latin America are potential markets for benzodiazepine drugs due to increased awareness of people toward healthcare, stress conditions, and surge in healthcare expenditure.
Key players operating in the global benzodiazepine drugs market include Pfizer Inc., F.Hoffmann-La Roche Ltd., Bausch Health Companies, Inc., Mylan, N.V., Teva Pharmaceutical Industries Ltd., H.Lundbeck A/S, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Apotex Inc., and Aurobindo Pharma.
Increasing Prevalence of Anxiety and Insomnia Disorders Draws Demand in Benzodiazepines Drugs Market
Global benzodiazepines drugs market is on a steady rise owing to the rising prevalence of anxiety disorders and increased levels of stress in global population. Stressful and fast paced lifestyles along with unhealthy work life balance are some of the contributory factors that precede mental health disturbances. Rising number of millennial population is prone to depression and comorbid anxiety disorders. According to a report issued by the World Health Organization (WHO) in 2015, the estimated number of people suffering from anxiety disorders around the world was 264 million at the time. Unhealthy social comparisons enabled by extended usage of social networking platforms among teenagers and millennials is one of the factors contributing to this growth in mental health disorders. Growing global geriatric population and high prevalence of insomnia or other sleep disorders are some of the key motivators for global benzodiazepines drugs market.
Products in global benzodiazepines drugs market are used for sedation, sleep inducing, and reducing anxiety. They can be both, short acting or long acting, depending on the type of product. Short acting drugs have greater risk of patient suffering from withdrawal symptoms. However, they work really well in the treatment of panic disorders. Long acting drugs in benzodiazepines drugs market have longer half-life, so the drug remains in the system for a longer time, working slowly. Withdrawal symptoms for long acting drugs are not as intense as the short acting ones, as they give the patient a prolonged period of time to adjust to the drug leaving the system. Use of products in benzodiazepines drug market assists countless people to manage their anxiety and lead a normal and safe life. However, benzodiazepine drugs can be abused as it induces sleep and causes sedation. Instances of benzodiazepine overdose can lead to the death of the consumer. These factors may hinder the growth in benzodiazepines drugs market.
The benzodiazepine drugs market has been segmented as follows:
|
Product |
|
|
Application |
|
|
Time of Action |
|
|
Distribution Channel |
|
|
Region |
|
Benzodiazepine drugs market to reach US $ 2,617.16 Mn by 2026
Benzodiazepine drugs market is projected to expand at a CAGR of 2.7% between 2018 and 2026
Benzodiazepine drugs market is driven by increase in prevalence of anxiety disorders, insomnia, seizures and comparatively higher number of prescriptions for benzodiazepines
North America accounted for a major share of the global enzodiazepine drugs market
Key players operating in the global benzodiazepine drugs market include Pfizer Inc., F.Hoffmann-La Roche Ltd., Bausch Health Companies, Inc., Mylan, N.V., Teva Pharmaceutical Industries Ltd., H.Lundbeck A/S, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Apotex Inc., and Aurobindo Pharma.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Benzodiazepine Drugs Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Benzodiazepine Drugs Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Regulatory Scenario by Region/globally
5.2. Pipeline Analysis
5.3. Overview of Growing Benzodiazepine Drug Misuse
6. Global Benzodiazepine Drugs Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
6.3.1. Alprazolam
6.3.2. Clonazepam
6.3.3. Diazepam
6.3.4. Lorazepam
6.3.5. Others
6.4. Global Benzodiazepine Drugs Market Attractiveness, by Product
7. Global Benzodiazepine Drugs Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
7.3.1. Anxiety
7.3.2. Insomnia
7.3.3. Alcohol Withdrawal
7.3.4. Seizures
7.3.5. Others
7.4. Global Benzodiazepine Drugs Market Attractiveness, by Application
8. Global Benzodiazepine Drugs Market Analysis and Forecast, by Time of Action
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
8.3.1. Ultra-short Acting
8.3.2. Short Acting
8.3.3. Long Acting
8.4. Global Benzodiazepine Drugs Market Attractiveness, by Time of Action
9. Global Benzodiazepine Drugs Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Others
9.4. Global Benzodiazepine Drugs Market Attractiveness, by Distribution Channel
10. Global Benzodiazepine Drugs Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Benzodiazepine Drugs Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East and Africa
10.3. Global Benzodiazepine Drugs Market Attractiveness, by Region
11. North America Benzodiazepine Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
11.2.1. Alprazolam
11.2.2. Clonazepam
11.2.3. Diazepam
11.2.4. Lorazepam
11.2.5. Others
11.3. North America Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
11.3.1. Anxiety
11.3.2. Insomnia
11.3.3. Alcohol Withdrawal
11.3.4. Seizures
11.3.5. Others
11.4. North America Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
11.4.1. Ultra-short Acting
11.4.2. Short Acting
11.4.3. Long Acting
11.5. North America Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Others
11.6. North America Benzodiazepine Drugs Market Value Forecast, by Country, 2016–2026
11.6.1. U.S.
11.6.2. Canada
11.7. North America Benzodiazepine Drugs Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By Time of Action
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Benzodiazepine Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
12.2.1. Alprazolam
12.2.2. Clonazepam
12.2.3. Diazepam
12.2.4. Lorazepam
12.2.5. Others
12.3. Europe Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
12.3.1. Anxiety
12.3.2. Insomnia
12.3.3. Alcohol Withdrawal
12.3.4. Seizures
12.3.5. Others
12.4. Europe Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
12.4.1. Ultra-short Acting
12.4.2. Short Acting
12.4.3. Long Acting
12.5. Europe Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Others
12.6. Europe Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Europe Benzodiazepine Drugs Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By Time of Action
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Benzodiazepine Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
13.2.1. Alprazolam
13.2.2. Clonazepam
13.2.3. Diazepam
13.2.4. Lorazepam
13.2.5. Others
13.3. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
13.3.1. Anxiety
13.3.2. Insomnia
13.3.3. Alcohol Withdrawal
13.3.4. Seizures
13.3.5. Others
13.4. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
13.4.1. Ultra-short Acting
13.4.2. Short Acting
13.4.3. Long Acting
13.5. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Others
13.6. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. Australia & New Zealand
13.6.5. Rest of APAC
13.7. Asia Pacific Benzodiazepine Drugs Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By Time of Action
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Benzodiazepine Drugs Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
14.2.1. Alprazolam
14.2.2. Clonazepam
14.2.3. Diazepam
14.2.4. Lorazepam
14.2.5. Others
14.3. Latin America Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
14.3.1. Anxiety
14.3.2. Insomnia
14.3.3. Alcohol Withdrawal
14.3.4. Seizures
14.3.5. Others
14.4. Latin America Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
14.4.1. Ultra-short Acting
14.4.2. Short Acting
14.4.3. Long Acting
14.5. Latin America Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Others
14.6. Latin America Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
14.6.1. Brazil
14.6.2.Mexico
14.6.3. Rest of LATAM
14.7. Latin America Benzodiazepine Drugs Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By Time of Action
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Benzodiazepine Drugs Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
15.2.1. Alprazolam
15.2.2. Clonazepam
15.2.3. Diazepam
15.2.4. Lorazepam
15.2.5. Others
15.3. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
15.3.1. Anxiety
15.3.2. Insomnia
15.3.3. Alcohol Withdrawal
15.3.4. Seizures
15.3.5. Others
15.4. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
15.4.1. Ultra-short Acting
15.4.2. Short Acting
15.4.3. Long Acting
15.5. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Others
15.6. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
15.6.1. GCC Countries
15.6.2.South Africa
15.6.3. Rest of MEA
15.7. Middle East & Africa Benzodiazepine Drugs Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Application
15.7.3. By Time of Action
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1.Market Player – Competition Matrix (By Tier and Size of companies)
16.2.Market Share Analysis By Tier and Size of the Company (2017)
16.3. Company Profiles
16.3.1. Pfizer Inc.
16.3.2. F.Hoffmann-La Roche Ltd.
16.3.3. Bausch Health Companies, Inc.
16.3.4. Mylan N.V.
16.3.5. Teva Pharmaceutical Industries Ltd.
16.3.6. H.Lundbeck A/S
16.3.7. Amneal Pharmaceuticals LLC
16.3.8. Sun Pharmaceutical Industries Ltd.
16.3.9. Apotex Inc.
16.3.10. Aurobindo Pharma
List of Tables
Table 01: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 03: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 04: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 05: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 08: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 09: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 10: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 11: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 13: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 14: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 15: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 16: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 17: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 18: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 19: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 20: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 21: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 23: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 24: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 25: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 26: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 28: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 29: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Time of Action, 2016–2026
Table 30: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
List of Figures
Figure 01: Global Benzodiazepine Drugs Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Benzodiazepine Drugs Market Value (US$ Mn) Share, by Product
Figure 03: Global Benzodiazepine Drugs Market Value (US$ Mn) Share, by Application
Figure 04: Global Benzodiazepine Drugs Market Value (US$ Mn) Share, by Time of Action
Figure 05: Global Benzodiazepine Drugs Market Value (US$ Mn) Share, by Distribution Channel
Figure 06: Global Benzodiazepine Drugs Market Value (US$ Mn) Forecast, 2016–2026
Figure 07: Global Benzodiazepine Drugs Market Value Share, by Product (2017)
Figure 08: Global Benzodiazepine Drugs Market Value Share, by Application (2017)
Figure 09: Global Benzodiazepine Drugs Market Value Share, by Time of Action (2017)
Figure 10: Global Benzodiazepine Drugs Market Value Share, by Distribution Channel (2017)
Figure 11: Global Benzodiazepine Drugs Market Value Share, by Region (2017)
Figure 12: Global Benzodiazepine Drugs Market Value Share Analysis, by Product, 2017 and 2026
Figure 13: Global Alprazolam Market Value (US$) and Y-o-Y Growth (%), 2016–2026
Figure 14: Global Clonazepam Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2026
Figure 15: Global Diazepam Market Value (US$) and Y-o-Y Growth (%), 2016–2026
Figure 16: Global Lorazepam Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2026
Figure 17: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 18: Benzodiazepine Drugs Market Attractiveness Analysis, by Product
Figure 19: Global Benzodiazepine Drugs Market Value Share Analysis, by Application, 2017 and 2026
Figure 20: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Anxiety, 2016–2026
Figure 21: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Insomnia, 2016–2026
Figure 22: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Alcohol Withdrawal, 2016–2026
Figure 23: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Seizures, 2016–2026
Figure 24: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 25: Benzodiazepine Drugs Market Attractiveness Analysis, by Application
Figure 26: Global Benzodiazepine Drugs Market Value Share Analysis, by Time of Action, 2017 and 2026
Figure 27: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Ultra-short Acting, 2016–2026
Figure 28: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Short Acting, 2016–2026
Figure 29: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Long Acting, 2016–2026
Figure 30: Benzodiazepine Drugs Market Attractiveness Analysis, by Time of Action
Figure 31: Global Benzodiazepine Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 32: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2016–2026
Figure 33: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Retails Pharmacies, 2016–2026
Figure 34: Global Benzodiazepine Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 35: Benzodiazepine Drugs Market Attractiveness Analysis, by Distribution Channel
Figure 36: Global Benzodiazepine Drugs Market Value Share, by Region, 2017 and 2026
Figure 37: Global Benzodiazepine Drugs Market Attractiveness Analysis, by Region, 2018–2026
Figure 38: North America Benzodiazepine Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 39: North America Benzodiazepine Drugs Market Value Share, by Country, 2017 and 2026
Figure 40: North America Benzodiazepine Drugs Market Attractiveness, by Country, 2017–2026
Figure 41: North America Benzodiazepine Drugs Market Value Share, by Product, 2017 and 2026
Figure 42: North America Benzodiazepine Drugs Market Attractiveness, by Product, 2017–2026
Figure 43: North America Benzodiazepine Drugs Market Value Share, by Application, 2017 and 2026
Figure 44: North America Benzodiazepine Drugs Market Attractiveness, by Application, 2017–2026
Figure 45: North America Benzodiazepine Drugs Market Value Share, by Time of Action, 2017 and 2026
Figure 46: North America Benzodiazepine Drugs Market Attractiveness, by Time of Action, 2017–2026
Figure 47: North America Benzodiazepine Drugs Market Value Share, by Distribution Channel, 2017 and 2026
Figure 48: North America Benzodiazepine Drugs Market Attractiveness, by Distribution Channel, 2017–2026
Figure 49: Europe Benzodiazepine Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 50: Europe Benzodiazepine Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 51: Europe Benzodiazepine Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
Figure 52: Europe Benzodiazepine Drugs Market Value Share, by Product, 2017 and 2026
Figure 53: Europe Benzodiazepine Drugs Market Attractiveness, by Product, 2017–2026
Figure 54: Europe Benzodiazepine Drugs Market Value Share, by Application, 2017 and 2026
Figure 55: Europe Benzodiazepine Drugs Market Attractiveness, by Application, 2017–2026
Figure 56: Europe Benzodiazepine Drugs Market Value Share, by Time of Action, 2017 and 2026
Figure 57: Europe Benzodiazepine Drugs Market Attractiveness, by Time of Action, 2017–2026
Figure 58: Europe Benzodiazepine Drugs Market Value Share, by Distribution Channel, 2017 and 2026
Figure 59: Europe Benzodiazepine Drugs Market Attractiveness, by Distribution Channel, 2017–2026
Figure 60: Asia Pacific Benzodiazepine Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 61: Asia Pacific Benzodiazepine Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 62: Asia Pacific Benzodiazepine Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
Figure 63: Asia Pacific Benzodiazepine Drugs Market Value Share, by Product, 2017 and 2026
Figure 64: Asia Pacific Benzodiazepine Drugs Market Attractiveness, by Product, 2017–2026
Figure 65: Asia Pacific Benzodiazepine Drugs Market Value Share, by Application, 2017 and 2026
Figure 66: Asia Pacific Benzodiazepine Drugs Market Attractiveness, by Application, 2017–2026
Figure 67: Asia Pacific Benzodiazepine Drugs Market Value Share, by Time of Action, 2017 and 2026
Figure 68: Asia Pacific Benzodiazepine Drugs Market Attractiveness, by Time of Action, 2017–2026
Figure 69: Asia Pacific Benzodiazepine Drugs Market Value Share, by Distribution Channel, 2017 and 2026
Figure 70: Asia Pacific Benzodiazepine Drugs Market Attractiveness, by Distribution Channel, 2017–2026
Figure 71: Latin America Benzodiazepine Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 72: Latin America Benzodiazepine Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 73: Latin America Benzodiazepine Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
Figure 74: Latin America Benzodiazepine Drugs Market Value Share, by Product, 2017 and 2026
Figure 75: Latin America Benzodiazepine Drugs Market Attractiveness, by Product, 2017–2026
Figure 76: Latin America Benzodiazepine Drugs Market Value Share, by Application, 2017 and 2026
Figure 77: Latin America Benzodiazepine Drugs Market Attractiveness, by Application, 2017–2026
Figure 78: Latin America Benzodiazepine Drugs Market Value Share, by Time of Action, 2017 and 2026
Figure 79: Latin America Benzodiazepine Drugs Market Attractiveness, by Time of Action, 2017–2026
Figure 80: Latin America Benzodiazepine Drugs Market Value Share, by Distribution Channel, 2017 and 2026
Figure 81: Latin America Benzodiazepine Drugs Market Attractiveness, by Distribution Channel, 2017–2026
Figure 82: Middle East & Africa Benzodiazepine Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 83: Middle East & Africa Benzodiazepine Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 84: Middle East & Africa Benzodiazepine Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
Figure 85: Middle East & Africa Benzodiazepine Drugs Market Value Share, by Product, 2017 and 2026
Figure 86: Middle East & Africa Benzodiazepine Drugs Market Attractiveness, by Product, 2017–2026
Figure 87: Middle East & Africa Benzodiazepine Drugs Market Value Share, by Application, 2017 and 2026
Figure 88: Middle East & Africa Benzodiazepine Drugs Market Attractiveness, by Application, 2017–2026
Figure 89: Middle East & Africa Benzodiazepine Drugs Market Value Share, by Time of Action, 2017 and 2026
Figure 90: Middle East & Africa Benzodiazepine Drugs Market Attractiveness, by Time of Action, 2017–2026
Figure 91: Middle East & Africa Benzodiazepine Drugs Market Value Share, by Distribution Channel, 2017 and 2026
Figure 92: Middle East & Africa Benzodiazepine Drugs Market Attractiveness, by Distribution Channel, 2017–2026
Figure 93: Market Share Analysis (%), 2017, by Tier and Size of the Company
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Benzodiazepine Drugs Market
*86 figures and 60 tables includes